In this article, we will look at the 5 Stocks Dominating The Market Today. For a deeper discussion and an extended list, please see 10 Stocks Dominating The Market Today.
Photo by Tima Miroshnichenko on Pexels
5. Brown-Forman Corp. (NYSE:BF-B)
Brown-Forman grew its share prices by 9.58 percent on Thursday to finish at $25.74 apiece, as investors loaded portfolios following news that it is set to merge with Pernod Ricard.
In a statement, Brown-Forman Corp. (NYSE:BF-B) confirmed that it is currently in discussions with Pernod Ricard for a potential merger, saying that it regularly explores and evaluates strategic opportunities.
“If agreed and subject to customary approvals, this partnership would be akin to a merger of equals, drawing from the talent and expertise of both companies, and creating value for shareholders,” Brown-Forman Corp. (NYSE:BF-B) said.
“Synergies from the contemplated combination are expected to be significant, creating a global spirits leader with enhanced scale, a powerful brand portfolio, and a balanced geographic footprint, all anchored by two iconic families,” it added.
The two companies have yet to reach an agreement, and a deal is not guaranteed.
Brown-Forman Corp. (NYSE:BF-B) is a global leader in the spirits industry, which owns Jack Daniel’s Family of Brands, Woodford Reserve, Old Forester, New Mix, el Jimador, Herradura, The Glendronach, Glenglassaugh, Benriach, Diplomático Rum, Gin Mare, Fords Gin, Chambord, and Slane.
4. NextDecade Corp. (NASDAQ:NEXT)
NextDecade rallied for a third straight day on Thursday, jumping 11.04 percent to finish at $8.15 apiece, as investors poured funds back into oil and gas stocks over growing doubts over a potential peace deal between the US and Iran.
NextDecade Corp. (NASDAQ:NEXT) rallied alongside its counterparts, tracking the energy rally. Crude benchmark indices Brent and WTI jumped by 4.13 percent and 3.28 percent, respectively, while natural gas was up by 0.36 percent.
Earlier this week, President Donald Trump announced that the US would halt from striking Iran for 10 days to give way for negotiations. However, market confidence appeared to have wavered after Iran denied that talks were underway.
With uncertainties ongoing, investors have resumed buying positions in stocks seen to benefit from the prolonged tensions, with concerns on supply crunch and higher prices expected to support higher profit margins for the said companies, including NextDecade Corp. (NASDAQ:NEXT).
Based in the US, NextDecade Corp. (NASDAQ:NEXT) owns and operates the Rio Grande project in Texas, which is currently under development. The facility is targeted to produce 30 million tons per annum of LNG for supply to its global customers.
3. Navan Inc. (NASDAQ:NAVN)
Navan soared by 43.28 percent on Thursday to finish at $13.11 apiece, as investors took heart from its strong revenue performance as well as three analysts’ bullish ratings for the stock.
In an earnings call on the same day, the travel technology platform said that it was able to grow its revenues by 31 percent to $702 million from $536.8 million year-on-year, on the back of higher revenues from usage, subscription, as well as increased gross booking and payments volume.
However, net loss expanded by 120 percent to $398 million from $181 million in 2024.
In the fourth quarter alone, revenues increased by 35 percent to $177.9 million from $131.99 million, while net loss increased by 56 percent to $72.76 million from $46.65 million.
Following the results, Navan Inc. (NASDAQ:NAVN) issued a 24-percent midpoint growth outlook for its full-year 2027 revenues, at a range of $866 million to $874 million.
For the first quarter alone, total revenues are expected to surge by 30 percent to a range of $204 million to $206 million.
“We enter FY’27 with a strong balance sheet and a clear path to continue expanding margins while investing in high-conviction innovation,” said Navan Inc. (NASDAQ:NAVN) CFO Aurelien Nolf.
2. Kodiak Sciences Inc. (NASDAQ:KOD)
Kodiak Sciences soared by 74.77 percent on Thursday to finish at $39.76 apiece, as investors took heart from the strong results of its clinical study for its diabetic retinopathy treatment.
In an updated report, Kodiak Sciences Inc. (NASDAQ:KOD) said that 62.5 percent of the enrolled patients achieved a more than 2-step improvement in diabetic retinopathy severity score, as compared with 3.3 percent of the sham group.
The patients were randomized to receive either a sham injection or Zenkuda via intravitreal injection at progressively extended intervals. Zenkuda also showed an 85-percent risk reduction in sight-threatening complications.
The drug candidate also demonstrated favorable safety and was well tolerated in the study, with a 0 percent intraocular inflammation rate and a 2.3 percent cataract adverse event rate, versus 1.6 percent with sham.
“We are very pleased to see that GLOW2 demonstrated a high degree of internal consistency across all datapoints. Importantly, GLOW2 also demonstrated strong external consistency when contextualized with GLOW1. Taken together, the combined GLOW1 and GLOW2 data package speaks volumes about the robustness of the data and the operational approach the team brought to the conduct of both studies,” Kodiak Sciences Inc. (NASDAQ:KOD) Chief Medical Officer J. Pablo Velazquez-Martin said.
1. VisionSys AI Inc. (NASDAQ:VSA)
VisionSys soared by 140.35 percent on Thursday to close at $1.37 apiece, as investors gobbled up shares to support its price boost after falling below the exchange requirement.
Under the rules of the Nasdaq, companies need to maintain a minimum bid price of $1 to continue listing their shares, or they could face a forced delisting on the exchange.
In the past 10 trading days, VisionSys AI Inc. (NASDAQ:VSA) has been trading below the $1 minimum bid price.
In other news, VisionSys AI Inc. (NASDAQ:VSA) earlier this month successfully sold $30.21 million of its shares, involving 14.25 billion shares at a price of $0.00212 apiece.
The purchase price was paid in either fiat money or in cryptocurrencies, in the sole discretion of the company.
Formerly Tarena International and TCTM Kids IT Education, VisionSys AI Inc. (NASDAQ:VSA) is a Beijing-based technology services company focusing on AI-powered brain machine interface systems, advanced algorithms, and software and hardware for biotechnology and healthcare.
While we acknowledge the potential of VSA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than VSA and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.
